Last 12 months
Inside the activity.
0 purchase rows · 12 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 09, 2020 Filed Oct 13, 2020 20:34 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
SaleOrdinary Shares | 15,677 | $188.24 | $2,951,038.48 |
DisclosureSEC source: 0001209191-20-054638 · doc4.xml · nonDerivative · entry 5 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,765 F5 · shares: This exercise of stock options and sale of a total of 15,677 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on June 2, 2020. F6 · price: Price reflects a weighted average sale price for multiple transactions ranging from $187.6950 to $188.68 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: 15,472 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 6,000 on June 1, 2021; 4,240 on May 31, 2022; 2,780 on May 31, 2023 and 2,452 on June 3, 2024. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 20:34 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
SaleOrdinary Shares | 6,000 | $187.17 | $1,123,020.00 |
DisclosureSEC source: 0001209191-20-054638 · doc4.xml · nonDerivative · entry 4 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,442 F3 · shares: This exercise of stock options and sale of a total of 6,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on June 2, 2020. F4 · price: Price reflects a weighted average sale price for multiple transactions ranging from $186.61 to $187.59 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: 15,472 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 6,000 on June 1, 2021; 4,240 on May 31, 2022; 2,780 on May 31, 2023 and 2,452 on June 3, 2024. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 20:34 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
Exercise / conversionOrdinary Shares | 27,920 | $53.52 | $1,494,278.40 |
DisclosureSEC source: 0001209191-20-054638 · doc4.xml · nonDerivative · entry 3 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,442 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: 15,472 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 6,000 on June 1, 2021; 4,240 on May 31, 2022; 2,780 on May 31, 2023 and 2,452 on June 3, 2024. Read SEC document |
| October 08, 2020 Filed Oct 13, 2020 20:34 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 80 | $0.00 Strike: $53.52 | $0.00 |
DisclosureSEC source: 0001209191-20-054638 · doc4.xml · derivative · entry 8 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,920 Underlying: Ordinary Shares · 80 shares Expires 2024-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: This option to purchase 28,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 28,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| October 08, 2020 Filed Oct 13, 2020 20:34 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
SaleOrdinary Shares | 80 | $187.00 | $14,960.00 |
DisclosureSEC source: 0001209191-20-054638 · doc4.xml · nonDerivative · entry 2 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,522 F2 · shares: This exercise of stock options and sale of a total of 80 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on June 2, 2020. F1 · balance_after: 15,472 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 6,000 on June 1, 2021; 4,240 on May 31, 2022; 2,780 on May 31, 2023 and 2,452 on June 3, 2024. Read SEC document |
| October 08, 2020 Filed Oct 13, 2020 20:34 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
Exercise / conversionOrdinary Shares | 80 | $53.52 | $4,281.60 |
DisclosureSEC source: 0001209191-20-054638 · doc4.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,602 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: 15,472 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 6,000 on June 1, 2021; 4,240 on May 31, 2022; 2,780 on May 31, 2023 and 2,452 on June 3, 2024. Read SEC document |
| October 06, 2020 Filed Oct 8, 2020 20:32 UTC |
Carestio Daniel ASr VP and Chief Operating Off
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 13,500 | $0.00 Strike: $77.07 | $0.00 |
DisclosureSEC source: 0001209191-20-054280 · doc4.xml · derivative · entry 7 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,500 Underlying: Ordinary Shares · 13,500 shares Expires 2027-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: This option to purchase 18,000 STERIS ordinary shares, of which 13,500 are fully vested and were exercised, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS"), in exchange for an option to purchase 18,000 Old STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| October 06, 2020 Filed Oct 8, 2020 20:32 UTC |
Carestio Daniel ASr VP and Chief Operating Off
|
SaleOrdinary Shares | 712 | $184.53 | $131,385.36 |
DisclosureSEC source: 0001209191-20-054280 · doc4.xml · nonDerivative · entry 6 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,314 F10 · shares: This exercise of stock options and sale of a total of 712 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 24, 2020. F11 · price: Price reflects a weighted average sale price for multiple transactions ranging from $184.30 to $184.85 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: 19,400 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,500 on June 1, 2021; 2,712 on May 31, 2022; 1,748 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023 and 1,108 on June 3, 2024. Read SEC document |
| October 06, 2020 Filed Oct 8, 2020 20:32 UTC |
Carestio Daniel ASr VP and Chief Operating Off
|
SaleOrdinary Shares | 2,777 | $183.67 | $510,051.59 |
DisclosureSEC source: 0001209191-20-054280 · doc4.xml · nonDerivative · entry 5 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,026 F8 · shares: This exercise of stock options and sale of a total of 2,777 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 24, 2020. F9 · price: Price reflects a weighted average sale price for multiple transactions ranging from $183.25 to $184.2450 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: 19,400 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,500 on June 1, 2021; 2,712 on May 31, 2022; 1,748 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023 and 1,108 on June 3, 2024. Read SEC document |
| October 06, 2020 Filed Oct 8, 2020 20:32 UTC |
Carestio Daniel ASr VP and Chief Operating Off
|
SaleOrdinary Shares | 3,444 | $182.86 | $629,769.84 |
DisclosureSEC source: 0001209191-20-054280 · doc4.xml · nonDerivative · entry 4 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,803 F6 · shares: This exercise of stock options and sale of a total of 3,444 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 24, 2020. F7 · price: Price reflects a weighted average sale price for multiple transactions ranging from $182.2150 to $183.19 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: 19,400 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,500 on June 1, 2021; 2,712 on May 31, 2022; 1,748 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023 and 1,108 on June 3, 2024. Read SEC document |
| October 06, 2020 Filed Oct 8, 2020 20:32 UTC |
Carestio Daniel ASr VP and Chief Operating Off
|
SaleOrdinary Shares | 2,903 | $181.25 | $526,168.75 |
DisclosureSEC source: 0001209191-20-054280 · doc4.xml · nonDerivative · entry 3 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,247 F4 · shares: This exercise of stock options and sale of a total of 2,903 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 24, 2020. F5 · price: Price reflects a weighted average sale price for multiple transactions ranging from $181.0050 to $181.8150 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: 19,400 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,500 on June 1, 2021; 2,712 on May 31, 2022; 1,748 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023 and 1,108 on June 3, 2024. Read SEC document |
| October 06, 2020 Filed Oct 8, 2020 20:32 UTC |
Carestio Daniel ASr VP and Chief Operating Off
|
SaleOrdinary Shares | 3,664 | $180.65 | $661,901.60 |
DisclosureSEC source: 0001209191-20-054280 · doc4.xml · nonDerivative · entry 2 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,150 F2 · shares: This exercise of stock options and sale of a total of 3,664 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 24, 2020. F3 · price: Price reflects a weighted average sale price for multiple transactions ranging from $180.00 to $180.9850 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: 19,400 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,500 on June 1, 2021; 2,712 on May 31, 2022; 1,748 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023 and 1,108 on June 3, 2024. Read SEC document |
| October 06, 2020 Filed Oct 8, 2020 20:32 UTC |
Carestio Daniel ASr VP and Chief Operating Off
|
Exercise / conversionOrdinary Shares | 13,500 | $77.07 | $1,040,445.00 |
DisclosureSEC source: 0001209191-20-054280 · doc4.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,814 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: 19,400 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,500 on June 1, 2021; 2,712 on May 31, 2022; 1,748 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023 and 1,108 on June 3, 2024. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 20:33 UTC |
Madsen JuliaSenior VP, Life Sciences
|
GrantOrdinary Shares | 1,396 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-053161 · doc4.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,641 F1 · shares: All 1,396 of these shares are restricted. The restrictions on these ordinary shares lapse as follows: 349 on October 1, 2021; 349 on October 3, 2022; 349 on October 2, 2023 and 349 on October 1, 2024. F2 · balance_after: 2,714 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 308 on June 1, 2021; 121 on June 1, 2021; 92 on June 1, 2021; 123 on June 1, 2021; 349 on October 1, 2021; 121 on May 31, 2022; 92 on May 31, 2022; 123 on June 1, 2022; 349 on October 3, 2022; 92 on May 31, 2023; 349 on October 2, 2023; 123 on June 1, 2023; 123 on June 3, 2024 and 349 on October 1, 2024. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 20:35 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 12,252 | $0.00 Strike: $53.52 | $0.00 |
DisclosureSEC source: 0001209191-20-053170 · doc4.xml · derivative · entry 3 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 12,252 shares Expires 2024-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This exercise and sale of a total of 12,252 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on August 5, 2020. F3 · derivative.exercise_date: This option to purchase 12,252 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 12,252 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 20:35 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
SaleOrdinary Shares | 12,252 | $178.00 | $2,180,856.00 |
DisclosureSEC source: 0001209191-20-053170 · doc4.xml · nonDerivative · entry 2 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,884 F1 · shares: This exercise and sale of a total of 12,252 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on August 5, 2020. F2 · balance_after: 15,980 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 6,000 on June 1, 2021; 3,636 on May 31, 2022; 2,502 on May 31, 2022; 1,504 on June 1, 2022; 834 on May 31, 2023; 752 on June 1, 2023 and 752 on June 3, 2024. Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 20:35 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
Exercise / conversionOrdinary Shares | 12,252 | $53.52 | $655,727.04 |
DisclosureSEC source: 0001209191-20-053170 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,136 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This exercise and sale of a total of 12,252 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on August 5, 2020. F2 · balance_after: 15,980 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 6,000 on June 1, 2021; 3,636 on May 31, 2022; 2,502 on May 31, 2022; 1,504 on June 1, 2022; 834 on May 31, 2023; 752 on June 1, 2023 and 752 on June 3, 2024. Read SEC document |
| September 18, 2020 Filed Sep 21, 2020 20:38 UTC |
Carestio Daniel ASr VP and Chief Operating Off
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $69.72 | $0.00 |
DisclosureSEC source: 0001209191-20-051291 · doc4.xml · derivative · entry 4 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 15,000 shares Expires 2026-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option to purchase 15,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS"), in exchange for an option to purchase 15,000 Old STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| September 18, 2020 Filed Sep 21, 2020 20:38 UTC |
Carestio Daniel ASr VP and Chief Operating Off
|
SaleOrdinary Shares | 206 | $176.03 | $36,262.18 |
DisclosureSEC source: 0001209191-20-051291 · doc4.xml · nonDerivative · entry 3 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,314 F4 · shares: This exercise of stock options and sale of a total of 128 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 24, 2020. F5 · price: Price reflects a weighted average sale price for multiple transactions ranging from $176.02 to $176.03 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: 19,400 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,500 on June 1, 2021; 2,712 on May 31, 2022; 1,748 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023 and 1,108 on June 3, 2024. Read SEC document |
| September 18, 2020 Filed Sep 21, 2020 20:38 UTC |
Carestio Daniel ASr VP and Chief Operating Off
|
SaleOrdinary Shares | 14,794 | $175.51 | $2,596,494.94 |
DisclosureSEC source: 0001209191-20-051291 · doc4.xml · nonDerivative · entry 2 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,520 F2 · shares: This exercise of stock options and sale of a total of 14,872 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 24, 2020. F3 · price: Price reflects a weighted average sale price for multiple transactions ranging from $175.02 to $176.00 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: 19,400 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,500 on June 1, 2021; 2,712 on May 31, 2022; 1,748 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023 and 1,108 on June 3, 2024. Read SEC document |
| September 18, 2020 Filed Sep 21, 2020 20:38 UTC |
Carestio Daniel ASr VP and Chief Operating Off
|
Exercise / conversionOrdinary Shares | 15,000 | $69.72 | $1,045,800.00 |
DisclosureSEC source: 0001209191-20-051291 · doc4.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,314 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: 19,400 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,500 on June 1, 2021; 2,712 on May 31, 2022; 1,748 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023 and 1,108 on June 3, 2024. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 20:33 UTC |
Carestio Daniel ASr VP and Chief Operating Off
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $67.98 | $0.00 |
DisclosureSEC source: 0001209191-20-050909 · doc4.xml · derivative · entry 5 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 8,000 shares Expires 2025-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: This option to purchase 8,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS"), in exchange for an option to purchase 8,000 Old STERIS ordinary shares for $67.98 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 20:33 UTC |
Carestio Daniel ASr VP and Chief Operating Off
|
SaleOrdinary Shares | 211 | $170.31 | $35,935.41 |
DisclosureSEC source: 0001209191-20-050909 · doc4.xml · nonDerivative · entry 4 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,314 F6 · shares: This exercise of stock options and sale of a total of 211 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 24, 2020. F7 · price: Price reflects a weighted average sale price for multiple transactions ranging from $170.2650 to $170.34 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: 19,400 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,500 on June 1, 2021; 2,712 on May 31, 2022; 1,748 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023 and 1,108 on June 3, 2024. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 20:33 UTC |
Carestio Daniel ASr VP and Chief Operating Off
|
SaleOrdinary Shares | 6,750 | $169.66 | $1,145,205.00 |
DisclosureSEC source: 0001209191-20-050909 · doc4.xml · nonDerivative · entry 3 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,525 F4 · shares: This exercise of stock options and sale of a total of 6,750 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 24, 2020. F5 · price: Price reflects a weighted average sale price for multiple transactions ranging from $169.22 to $170.2150 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: 19,400 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,500 on June 1, 2021; 2,712 on May 31, 2022; 1,748 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023 and 1,108 on June 3, 2024. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 20:33 UTC |
Carestio Daniel ASr VP and Chief Operating Off
|
SaleOrdinary Shares | 1,039 | $168.94 | $175,528.66 |
DisclosureSEC source: 0001209191-20-050909 · doc4.xml · nonDerivative · entry 2 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,275 F2 · shares: This exercise of stock options and sale of a total of 1,039 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 24, 2020. F3 · price: Price reflects a weighted average sale price for multiple transactions ranging from $168.17 to $169.17 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: 19,400 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,500 on June 1, 2021; 2,712 on May 31, 2022; 1,748 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023 and 1,108 on June 3, 2024. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 20:33 UTC |
Carestio Daniel ASr VP and Chief Operating Off
|
Exercise / conversionOrdinary Shares | 8,000 | $67.98 | $543,840.00 |
DisclosureSEC source: 0001209191-20-050909 · doc4.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,314 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: 19,400 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,500 on June 1, 2021; 2,712 on May 31, 2022; 1,748 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023 and 1,108 on June 3, 2024. Read SEC document |
| September 14, 2020 Filed Sep 15, 2020 20:34 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
SaleOrdinary Shares | 2,000 | $167.00 | $334,000.00 |
DisclosureSEC source: 0001209191-20-050468 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,884 F1 · shares: This sale of a total of 2,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on August 5, 2020. F2 · balance_after: 15,980 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 6,000 on June 1, 2021; 3,636 on May 31, 2022; 2,502 on May 31, 2022; 1,504 on June 1, 2022; 834 on May 31, 2023; 752 on June 1, 2023 and 752 on June 3, 2024. Read SEC document |
| August 25, 2020 Filed Aug 26, 2020 20:33 UTC |
Breeden Richard CDirector
|
SaleOrdinary Shares | 506 | $154.94 | $78,399.64 |
DisclosureSEC source: 0001209191-20-048397 · doc4.xml · nonDerivative · entry 5 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Below Disclosed balance after: 27,242 F7 · price: Price reflects a weighted average sale price for multiple transactions ranging from $154.86 to $155.055 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.nature: Richard C. Breeden is the managing member of Breeden Capital Partners LLC, and managing member and chairman and chief executive officer of Breeden Capital Management LLC. Breeden Capital Partners LLC is in turn the general partner of Breeden Partners L.P. (the "Fund"). F3 · ownership.nature: Pursuant to Rule 16a-1(a)(2)(ii)(B) of the Securities Exchange Act of 1934, as amended, Mr. Breeden in his capacity as managing member, as well as chairman and chief executive officer of Breeden Capital Management LLC and as the managing member of Breeden Capital Partners LLC, may be deemed to be the indirect beneficial owner of the ordinary shares owned by the Fund and its General Partner, and may be deemed to have beneficial ownership of all such shares. Read SEC document |
| August 25, 2020 Filed Aug 26, 2020 20:33 UTC |
Breeden Richard CDirector
|
SaleOrdinary Shares | 19,494 | $154.36 | $3,009,093.84 |
DisclosureSEC source: 0001209191-20-048397 · doc4.xml · nonDerivative · entry 4 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Below Disclosed balance after: 27,748 F6 · price: Price reflects a weighted average sale price for multiple transactions ranging from $153.83 to $154.785 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.nature: Richard C. Breeden is the managing member of Breeden Capital Partners LLC, and managing member and chairman and chief executive officer of Breeden Capital Management LLC. Breeden Capital Partners LLC is in turn the general partner of Breeden Partners L.P. (the "Fund"). F3 · ownership.nature: Pursuant to Rule 16a-1(a)(2)(ii)(B) of the Securities Exchange Act of 1934, as amended, Mr. Breeden in his capacity as managing member, as well as chairman and chief executive officer of Breeden Capital Management LLC and as the managing member of Breeden Capital Partners LLC, may be deemed to be the indirect beneficial owner of the ordinary shares owned by the Fund and its General Partner, and may be deemed to have beneficial ownership of all such shares. Read SEC document |
| August 24, 2020 Filed Aug 26, 2020 20:33 UTC |
Breeden Richard CDirector
|
SaleOrdinary Shares | 946 | $154.32 | $145,986.72 |
DisclosureSEC source: 0001209191-20-048397 · doc4.xml · nonDerivative · entry 3 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Below Disclosed balance after: 47,242 F5 · price: Price reflects a weighted average sale price for multiple transactions ranging from $154.12 to $154.56 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.nature: Richard C. Breeden is the managing member of Breeden Capital Partners LLC, and managing member and chairman and chief executive officer of Breeden Capital Management LLC. Breeden Capital Partners LLC is in turn the general partner of Breeden Partners L.P. (the "Fund"). F3 · ownership.nature: Pursuant to Rule 16a-1(a)(2)(ii)(B) of the Securities Exchange Act of 1934, as amended, Mr. Breeden in his capacity as managing member, as well as chairman and chief executive officer of Breeden Capital Management LLC and as the managing member of Breeden Capital Partners LLC, may be deemed to be the indirect beneficial owner of the ordinary shares owned by the Fund and its General Partner, and may be deemed to have beneficial ownership of all such shares. Read SEC document |
| August 24, 2020 Filed Aug 26, 2020 20:33 UTC |
Breeden Richard CDirector
|
SaleOrdinary Shares | 4,307 | $153.33 | $660,392.31 |
DisclosureSEC source: 0001209191-20-048397 · doc4.xml · nonDerivative · entry 2 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Below Disclosed balance after: 48,188 F4 · price: Price reflects a weighted average sale price for multiple transactions ranging from $152.94 to $153.91 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.nature: Richard C. Breeden is the managing member of Breeden Capital Partners LLC, and managing member and chairman and chief executive officer of Breeden Capital Management LLC. Breeden Capital Partners LLC is in turn the general partner of Breeden Partners L.P. (the "Fund"). F3 · ownership.nature: Pursuant to Rule 16a-1(a)(2)(ii)(B) of the Securities Exchange Act of 1934, as amended, Mr. Breeden in his capacity as managing member, as well as chairman and chief executive officer of Breeden Capital Management LLC and as the managing member of Breeden Capital Partners LLC, may be deemed to be the indirect beneficial owner of the ordinary shares owned by the Fund and its General Partner, and may be deemed to have beneficial ownership of all such shares. Read SEC document |
| August 24, 2020 Filed Aug 26, 2020 20:33 UTC |
Breeden Richard CDirector
|
SaleOrdinary Shares | 19,747 | $152.45 | $3,010,430.15 |
DisclosureSEC source: 0001209191-20-048397 · doc4.xml · nonDerivative · entry 1 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Below Disclosed balance after: 52,495 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $151.885 to $152.86 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.nature: Richard C. Breeden is the managing member of Breeden Capital Partners LLC, and managing member and chairman and chief executive officer of Breeden Capital Management LLC. Breeden Capital Partners LLC is in turn the general partner of Breeden Partners L.P. (the "Fund"). F3 · ownership.nature: Pursuant to Rule 16a-1(a)(2)(ii)(B) of the Securities Exchange Act of 1934, as amended, Mr. Breeden in his capacity as managing member, as well as chairman and chief executive officer of Breeden Capital Management LLC and as the managing member of Breeden Capital Partners LLC, may be deemed to be the indirect beneficial owner of the ordinary shares owned by the Fund and its General Partner, and may be deemed to have beneficial ownership of all such shares. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 20:30 UTC |
Majors Cary LSr VP N America Com Operations
|
Exercise / conversionEmployee Stock Options (right to buy) · Derivative | 3,000 | $0.00 Strike: $69.72 | $0.00 |
DisclosureSEC source: 0001209191-20-046371 · doc4.xml · derivative · entry 5 Majors Cary L · CIK 0001776271 · Sr VP N America Com Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,000 shares Expires 2026-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is part of an option to purchase 12,000 STERIS ordinary shares, which are fully vested, which was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 12,000 Old STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 20:30 UTC |
Majors Cary LSr VP N America Com Operations
|
SaleOrdinary Shares | 218 | $155.88 | $33,981.84 |
DisclosureSEC source: 0001209191-20-046371 · doc4.xml · nonDerivative · entry 4 Majors Cary L · CIK 0001776271 · Sr VP N America Com Operations 10b5-1 filing: Not disclosed Ownership: Indirect · By 401(k) Disclosed balance after: 0 F3 · price: 401(k) Plan STERIS shares liquidated at the price of $155.88 per share on August 10, 2020, constituting the Reporting Person's entire interest in STERIS shares under the 401(k) Plan. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 20:30 UTC |
Majors Cary LSr VP N America Com Operations
|
SaleOrdinary Shares | 2,355 | $155.62 | $366,485.10 |
DisclosureSEC source: 0001209191-20-046371 · doc4.xml · nonDerivative · entry 3 Majors Cary L · CIK 0001776271 · Sr VP N America Com Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,120 F2 · balance_after: 13,620 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 6,500 on June 1, 2021; 2,520 on May 31, 2022; 2,224 on May 31, 2023; and 2,376 on June 3, 2024. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 20:30 UTC |
Majors Cary LSr VP N America Com Operations
|
SaleOrdinary Shares | 3,000 | $156.84 | $470,530.50 |
DisclosureSEC source: 0001209191-20-046371 · doc4.xml · nonDerivative · entry 2 Majors Cary L · CIK 0001776271 · Sr VP N America Com Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,475 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $156.7500 to $156.8950 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 20:30 UTC |
Majors Cary LSr VP N America Com Operations
|
Exercise / conversionOrdinary Shares | 3,000 | $69.72 | $209,160.00 |
DisclosureSEC source: 0001209191-20-046371 · doc4.xml · nonDerivative · entry 1 Majors Cary L · CIK 0001776271 · Sr VP N America Com Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,475 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2020 Filed Aug 10, 2020 20:31 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 51,000 | $0.00 Strike: $77.07 | $0.00 |
DisclosureSEC source: 0001209191-20-045947 · doc4.xml · derivative · entry 17 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,000 Underlying: Ordinary Shares · 51,000 shares Expires 2027-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F15 · derivative.exercise_date: This option is part of an option to purchase 136,000 STERIS ordinary shares, of which 102,000 are fully vested, which was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 136,000 Old STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| August 07, 2020 Filed Aug 10, 2020 20:31 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
SaleOrdinary Shares | 709 | $156.79 | $111,164.11 |
DisclosureSEC source: 0001209191-20-045947 · doc4.xml · nonDerivative · entry 14 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,302 F11 · price: Price reflects a weighted average sale price for multiple transactions ranging from $156.4850 to $157.0300 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F12 · balance_after: These 76,302 ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit. F13 · balance_after: 26,853 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,000 on June 1, 2021; 3,097 on June 1, 2021; 2,597 on June 1, 2021; 2,217 on June 1, 2021; 3,097 on May 31, 2022; 2,597 on May 31, 2022; 2,217 on June 1, 2022; 2,597 on May 31, 2023; 2,217 on June 1, 2023; and 2,217 on June 3, 2024. Read SEC document |
| August 07, 2020 Filed Aug 10, 2020 20:31 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
SaleOrdinary Shares | 5,874 | $155.79 | $915,110.46 |
DisclosureSEC source: 0001209191-20-045947 · doc4.xml · nonDerivative · entry 13 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,011 F10 · price: Price reflects a weighted average sale price for multiple transactions ranging from $155.4300 to $156.3950 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 07, 2020 Filed Aug 10, 2020 20:31 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
SaleOrdinary Shares | 9,799 | $155.03 | $1,519,138.97 |
DisclosureSEC source: 0001209191-20-045947 · doc4.xml · nonDerivative · entry 12 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,885 F9 · price: Price reflects a weighted average sale price for multiple transactions ranging from $154.4250 to $155.4200 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 07, 2020 Filed Aug 10, 2020 20:31 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
SaleOrdinary Shares | 11,552 | $154.05 | $1,779,585.60 |
DisclosureSEC source: 0001209191-20-045947 · doc4.xml · nonDerivative · entry 11 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,684 F8 · price: Price reflects a weighted average sale price for multiple transactions ranging from $153.4200 to $154.4200 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 07, 2020 Filed Aug 10, 2020 20:31 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
SaleOrdinary Shares | 23,066 | $152.91 | $3,527,022.06 |
DisclosureSEC source: 0001209191-20-045947 · doc4.xml · nonDerivative · entry 10 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,236 F7 · price: Price reflects a weighted average sale price for multiple transactions ranging from $152.3900 to $153.3800 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 07, 2020 Filed Aug 10, 2020 20:31 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
Exercise / conversionOrdinary Shares | 51,000 | $77.07 | $3,930,570.00 |
DisclosureSEC source: 0001209191-20-045947 · doc4.xml · nonDerivative · entry 9 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,302 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2020 Filed Aug 6, 2020 20:30 UTC |
FELDMANN CYNTHIA LDirector
|
Tax withholdingOrdinary Shares | 293 | $158.00 | $46,294.00 |
DisclosureSEC source: 0001209191-20-045470 · doc4.xml · nonDerivative · entry 2 FELDMANN CYNTHIA L · CIK 0001264554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 705 F1 · shares: Ordinary shares withheld to satisfy taxes. F1 · price: Ordinary shares withheld to satisfy taxes. Read SEC document |
| August 06, 2020 Filed Aug 6, 2020 20:30 UTC |
FELDMANN CYNTHIA LDirector
|
GrantOrdinary Shares | 658 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-045470 · doc4.xml · nonDerivative · entry 1 FELDMANN CYNTHIA L · CIK 0001264554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 998 Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:31 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 51,000 | $0.00 Strike: $77.07 | $0.00 |
DisclosureSEC source: 0001209191-20-045947 · doc4.xml · derivative · entry 16 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Underlying: Ordinary Shares · 51,000 shares Expires 2027-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F15 · derivative.exercise_date: This option is part of an option to purchase 136,000 STERIS ordinary shares, of which 102,000 are fully vested, which was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 136,000 Old STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:31 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 28,085 | $0.00 Strike: $69.72 | $0.00 |
DisclosureSEC source: 0001209191-20-045947 · doc4.xml · derivative · entry 15 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 28,085 shares Expires 2026-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F14 · derivative.exercise_date: This option is part of an option to purchase 112,340 STERIS ordinary shares, which are fully vested, which was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 112,349 Old STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:31 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
SaleOrdinary Shares | 1,996 | $156.87 | $313,112.52 |
DisclosureSEC source: 0001209191-20-045947 · doc4.xml · nonDerivative · entry 8 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,302 F6 · price: Price reflects a weighted average sale price for multiple transactions ranging from $156.6550 to $157.1950 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:31 UTC |
Rosebrough Walter M JrDirector · President & CEO
|
SaleOrdinary Shares | 13,137 | $155.88 | $2,047,795.56 |
DisclosureSEC source: 0001209191-20-045947 · doc4.xml · nonDerivative · entry 7 Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,298 F5 · price: Price reflects a weighted average sale price for multiple transactions ranging from $155.6500 to $156.6400 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.